logo

For the Inventor, By the Inventor

Milan, Italy

Dante Nardi

USPTO Granted Patents = 15

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 69(Granted Patents)


Company Filing History:

goldMedal9 out of 42 
 
Recordati S.a. Chemical and Pharmaceutical Company
 patents
silverMedal6 out of 9 
 
Recordati S.a.
 patents

Years Active: 1976-1990

Loading Chart...
15 patents (USPTO):Explore Patents
1. 4968832 - Novel asymmetric diesters of (1990-11-06),
2. 4940711 - Antihypertensive N-piperazinylalkanoylanilides (1990-07-10),
3. 4806534 - Therapeutically active flavonyl-1,4-dihydrophyridines (1989-02-21),
4. 4772621 - Antihypertensive diphenylpropyl aminopropyl ester of (1988-09-20),
5. 4705797 - N-(3,3-diphenylpropyl) aminoethyl esters of (1987-11-10),
6. 4675319 - Antianaphylactic and antibronchospastic piperazinyl-(N-substituted (1987-06-23),
7. 4634712 - Antihypertensive esters of 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl or (1987-01-06),
8. 4550115 - Certain piperidino-lower-alkylene esters of (1985-10-29),
9. 4510140 - Therapeutically effective (1985-04-09),
10. 4507308 - Analgesically or anti-inflammatory effective 4-quinolyl anthranilic acid (1985-03-26),
11. 4482561 - Therapeutically effective piperidyl (1984-11-13),
12. 4438133 - Therapeutically effective derivatives of cystine (1984-03-20),
13. 4275071 - Imidazole derivatives (1981-06-23),
14. 4221803 - Substituted dibenzyl ethers and pharmaceutical compositions containing (1980-09-09),
15. 3933793 - Therapeutically active 2-aminoalkylthio-3H-1.5-benzodiazepines and (1976-01-20),

Title: The Innovative Contributions of Dante Nardi

Introduction

Dante Nardi is a prominent inventor based in Milan, Italy, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Nardi has made remarkable advancements in the development of antihypertensive agents and other medicinal compounds.

Latest Patents

Among his latest patents, Nardi has developed novel asymmetric diesters that serve as antihypertensive and coronary dilating agents. These compounds are derived from 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylic acid and are characterized by their complex chemical structures. His work also includes the formulation of N-piperazinylalkanoylanilides, which are designed to function as effective antihypertensive agents. These innovative compounds showcase Nardi's expertise in medicinal chemistry and his commitment to improving healthcare outcomes.

Career Highlights

Throughout his career, Nardi has worked with Recordati S.a., a well-known chemical and pharmaceutical company. His role in this organization has allowed him to contribute to the development of various pharmaceutical products, further solidifying his reputation as a leading inventor in the industry.

Collaborations

Nardi has collaborated with notable colleagues such as Gabriele Graziani and Amedeo Leonardi. These partnerships have fostered a collaborative environment that has led

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…